File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Engineering Microcapsules for Simultaneous Delivery of Combinational Therapeutics

TitleEngineering Microcapsules for Simultaneous Delivery of Combinational Therapeutics
Authors
Keywordsbiodegradabilities
combinational treatments
local co‐deliveries
microcapsules
monodispersities
Issue Date2020
PublisherJohn Wiley & Sons. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2365-709X
Citation
Advanced Materials Technologies, 2020, v. 5 n. 11, p. article no. 2000623 How to Cite?
AbstractThe combination of chemo‐ and photothermal therapy is an effective strategy to improve clinical outcomes and minimize side effects. For simultaneously delivering chemo‐ and photothermal agents to the tumor region to exert their synergistic effect, an efficient and safe drug co‐delivery platform is in great need. Microcapsules (MCs) are promising drug carriers for local treatment of tumors. However, their applications in chemo‐photothermal combinational therapy have not been fully explored. Herein, novel doxorubicin (DOX) and indocyanine green (ICG)‐incorporated microcapsules (DIMCs) are reported for highly efficient delivery of combinational therapeutics. To obtain DIMCs with precise configuration and controlled drug release characteristics, the microfluidic double‐emulsion templating method is adopted and factors dominating the size and morphology of DIMCs are investigated. Under optimized conditions, DIMCs with well‐defined hydrogel cores and polymeric shells can be steadily prepared, which are hydrolytically degradable, allow for pH‐sensitive sustained release of the drug payload, and show excellent photothermal effects. The in vitro experiment shows that DIMCs exhibit significantly enhanced antitumor efficiency owing to the synergistic effects of chemo‐ and photothermal actives, showing great potential as a new therapeutic platform in local treatment of cancers.
Persistent Identifierhttp://hdl.handle.net/10722/294092
ISSN
2021 Impact Factor: 8.856
2020 SCImago Journal Rankings: 2.184
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHuang, L-
dc.contributor.authorZhou, J-
dc.contributor.authorChen, Y-
dc.contributor.authorLI, W-
dc.contributor.authorHAN, X-
dc.contributor.authorWang, L-
dc.date.accessioned2020-11-23T08:26:13Z-
dc.date.available2020-11-23T08:26:13Z-
dc.date.issued2020-
dc.identifier.citationAdvanced Materials Technologies, 2020, v. 5 n. 11, p. article no. 2000623-
dc.identifier.issn2365-709X-
dc.identifier.urihttp://hdl.handle.net/10722/294092-
dc.description.abstractThe combination of chemo‐ and photothermal therapy is an effective strategy to improve clinical outcomes and minimize side effects. For simultaneously delivering chemo‐ and photothermal agents to the tumor region to exert their synergistic effect, an efficient and safe drug co‐delivery platform is in great need. Microcapsules (MCs) are promising drug carriers for local treatment of tumors. However, their applications in chemo‐photothermal combinational therapy have not been fully explored. Herein, novel doxorubicin (DOX) and indocyanine green (ICG)‐incorporated microcapsules (DIMCs) are reported for highly efficient delivery of combinational therapeutics. To obtain DIMCs with precise configuration and controlled drug release characteristics, the microfluidic double‐emulsion templating method is adopted and factors dominating the size and morphology of DIMCs are investigated. Under optimized conditions, DIMCs with well‐defined hydrogel cores and polymeric shells can be steadily prepared, which are hydrolytically degradable, allow for pH‐sensitive sustained release of the drug payload, and show excellent photothermal effects. The in vitro experiment shows that DIMCs exhibit significantly enhanced antitumor efficiency owing to the synergistic effects of chemo‐ and photothermal actives, showing great potential as a new therapeutic platform in local treatment of cancers.-
dc.languageeng-
dc.publisherJohn Wiley & Sons. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2365-709X-
dc.relation.ispartofAdvanced Materials Technologies-
dc.rightsPreprint This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. Postprint This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.-
dc.subjectbiodegradabilities-
dc.subjectcombinational treatments-
dc.subjectlocal co‐deliveries-
dc.subjectmicrocapsules-
dc.subjectmonodispersities-
dc.titleEngineering Microcapsules for Simultaneous Delivery of Combinational Therapeutics-
dc.typeArticle-
dc.identifier.emailWang, L: lqwang@hku.hk-
dc.identifier.authorityWang, L=rp00184-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1002/admt.202000623-
dc.identifier.scopuseid_2-s2.0-85090089041-
dc.identifier.hkuros319568-
dc.identifier.volume5-
dc.identifier.issue11-
dc.identifier.spagearticle no. 2000623-
dc.identifier.epagearticle no. 2000623-
dc.identifier.isiWOS:000564973400001-
dc.publisher.placeHong Kong-
dc.identifier.issnl2365-709X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats